Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India [Phase 3]
Phase 3 clinical trial evaluating the 13-valent pneumococcal conjugate vaccine in healthy infants in India has completed and results have be…
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
A completed clinical trial investigated Streptococcus pneumoniae presence in the noses and throats of infants with acute otitis media.
-
CLINICAL_TRIALS trial_result · 2010-06-14Clinical Trial Update: Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ [Phase 3]
Phase 3 trial in children evaluating primary vaccination with a pneumococcal conjugate vaccine (GSK 1024850A or Prevenar) alongside Hib vacc…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule [Phase 2]
A Phase 2 clinical trial evaluating reactogenicity and immunogenicity of a pneumococcal conjugate vaccine when given as a booster or in a tw…
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Study Evaluating Prevenar Vaccine in Healthy Infants [Phase 4]
A Phase 4 trial evaluating the Prevenar pneumococcal vaccine in healthy infants has been completed; Wyeth is now part of Pfizer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-07-24Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age [Phase 3]
Phase 3 trial update for a pneumococcal conjugate vaccine in healthy infants aged 6 to 8 weeks, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 1]
A Phase 1 study of the 7-valent pneumococcal conjugate vaccine (Prevnar) in healthy infants has completed, with results posted in 2009. The …
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: Pneumococcal Vaccination of Fiji Infants [Phase 2]
A Phase 2 clinical trial evaluating pneumococcal vaccination in infants in Fiji has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Study Investigating Administration of Prevenar for Post-Marketing Surveillance
A completed post-marketing surveillance clinical trial evaluating the administration of Prevenar, a pneumococcal conjugate vaccine, for pneu…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Safety and Local Tolerability of Prevenar in Indian Children
A clinical trial assessing the safety and local tolerability of Prevenar in Indian children has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children [Phase 4]
Phase 4 clinical trial comparing Prevenar (PCV13) with Pneumovax 23 in reducing pneumococcal carriage in children has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-20Clinical Trial Update: Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®
This clinical trial evaluated Streptococcus pneumoniae nasopharyngeal carriage in children receiving Prevnar and has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-20Clinical Trial Update: Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes [Phase 3]
A Phase 3 efficacy trial assessed two pneumococcal conjugate vaccines (PncCRM and PncOMPC) for preventing acute otitis media due to vaccine-…
-
CLINICAL_TRIALS trial_result · 2006-08-24Clinical Trial Update: Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants. [Phase 4]
A Phase 4 immunogenicity and safety study of the Pneumococcal 7-valent conjugate vaccine in infants with sickle cell disease has been termin…